If you used your free time on Saturday or Sunday to watch football, you may have seen an ad run by Joe Biden’s campaign in which the narrator says that Biden won’t raise taxes on anyone earning less than $400,000 annually. The ad perpetuates the myth that the Tax Cuts and Jobs Act was a “tax cut for the rich.” As Chris Edwards of the Cato Institute notes, the Tax Cuts and Jobs Act “provided the largest percentage tax cuts to the bottom two quintiles—that is, the bottom 40 percent of U.S. households.”

Welcome to the new and improved Regulatory Action Center (RAC) Review! RAC proudly keeps you up to date on what we’re up to and what we’re keeping our eyes on here in the swamp. We offer resources for you to get involved in the rulemaking process to hold unelected bureaucrats accountable and occasionally offer praise in the event they have a good impulse. We will also highlight the incredible work our activists have done to advance the principles of smaller government, lower taxes, free markets, personal liberty, and the rule of law. For more ways to get involved and stay informed, check the links at the bottom of this post.

On Wednesday, the Congressional Budget Office (CBO) released separate reports on the ten-year budget outlook and the financial outlook for major federal trust funds. The reports show the impact of COVID-19 on the economy, the failure of Congress to responsibly manage federal spending, and the cost of doing nothing to put federal entitlement programs on a sustainable financial path.

Prices for prescription drugs in the U.S. are far too high. There is no denying this sad reality. According to an analysis done by the House Ways and Means Committee, the U.S. pays roughly four times as much as 11 similar nations for prescription drugs. For millions of patients, families, and caregivers, this is unacceptable. Policymakers are right when they say something needs to be done.

Welcome to FreedomWorks Foundation’s third regulatory review of 2020! Our Regulatory Action Center proudly updates you with the latest regulatory actions from the swamp.This week, we bring you a special coronavirus edition, highlighting some of the positive ways our government is responding administratively. Check back next week for the next edition.

Famed Chicago School economist Milton Friedman had many strong opinions over the course of his lifetime. Many of those shaped the way we look at the world and the way we look at the economy. However, Friedman also dedicated a good amount of his time to criticizing government health policy, particularly the Food and Drug Administration (FDA).

There has been some recent uproar over a regulation proposed by the Centers for Medicare and Medicaid Services designed to strengthen Medicaid, the government program that provides health insurance coverage for individuals below certain income levels. The regulation has sparked a curious bipartisan backlash from Capitol Hill and from state governments.